Guardant’s New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases.

Barron's·Sep 26

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A new blood test has been developed that can detect many different cancers, including colorectal cancer. The test has received approval for colorectal cancer screening and has shown promise in detecting cancer progression in chemotherapy patients. It is being launched in multiple markets, with potential applications for detecting other diseases beyond cancer.

Full coverage

Many people skip colonoscopies. Experts just added a blood test to the options.

The Washington Post·May 27

Blood tests for colorectal cancer screening have arrived

Drug Discovery News·Dec 11

Guardant blood test gives early warning of cancer progression in chemo patients, study finds

Fierce Biotech·Nov 10

New blood test can detect colorectal cancer. Tulane graduate talks medical technology.

NOLA.com·Mar 4

Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

Business Wire·Mar 16

A Silicon Valley engineer cracked the code to find signs of colon cancer in your blood

Business Insider·Oct 18

Guardant gets FDA nod for next-gen cancer mutation blood test

Mugglehead Investment Magazine·May 24

Shield Blood Test Approved for Colorectal Cancer Screening

National Cancer Institute (.gov)·Oct 11

View original report at Barron's ↗

Fetching the latest headlines…